PD-L1 is a membrane bound protein on tumour cells, and other cell types in the TME, whereas PD-1, the corresponding receptor, is expressed on immune cells, such as activated T lymphocytes, B lymphocytes, CD4+ and CD8+ T-cells, activated monocytes, and dendritic cells [52,161]. Here, CD8A is linked to neoplasm.